Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

IL-1β, in contrast to TNFα, is pivotal in blood-induced cartilage damage and is a potential target for therapy

Lize F. D. van Vulpen, Roger E. G. Schutgens, Katja Coeleveld, Els C. Alsema, Goris Roosendaal, Simon C. Mastbergen, Floris P. J. G. Lafeber

Blood (2015) 126 (19): 2239–2246.

https://doi.org/10.1182/blood-2015-03-635524

Published: 2015

Journal Articles

Interleukin-1β Is Essential for Blood-Induced Cartilage Damage I n Vitro

Lize F.D. van Vulpen, MD, Goris Roosendaal, MD PhD, Simon C. Mastbergen, PhD, Floris P.J.G. Lafeber, PhD, Roger E.G. Schutgens, MD PhD

Blood (2014) 124 (21): 240.

https://doi.org/10.1182/blood.V124.21.240.240

Published: 2014

Journal Articles

Insufficient evidence to suggest less stringent therapy in hemophilia B?

Ingrid E. M. den Uijl, Goris Roosendaal, Kathelijn Fischer

Blood (2009) 114 (23): 4907.

https://doi.org/10.1182/blood-2009-08-241240

Published: 2009

Journal Articles

Biomarkers of Cartilage and Bone Damage as a Measure of Joint Damage in Haemophilia.

Nathalie W.D. Jansen, PhD, Goris Roosendaal, MD, PhD, Bjorn Lundin, MD, PhD, Lily Heijnen, MD, PhD, Matthias Theobald, MD, PhD, Johannes W.J. Bijlsma, MD, PhD, Floris P.J.G. Lafeber, PhD

Blood (2008) 112 (11): 1214.

https://doi.org/10.1182/blood.V112.11.1214.1214

Published: 2008

Journal Articles

Very Rapid Clearance after a Joint Bleed Knee Can Not Prevent Adverse Effects on Cartilage and Synovial Tissue: A Canine in Vivo Study.

Nathalie W.D. Jansen, PhD, Goris Roosendaal, MD, PhD, Marion Wenting, Herman A.W. Hazewinkel, PhD, Johannes W.J. Bijlsma, MD, PhD, Matthias Theobald, MD, PhD, Floris P.J.G. Lafeber, PhD

Blood (2008) 112 (11): 2273.

https://doi.org/10.1182/blood.V112.11.2273.2273

Published: 2008

Journal Articles

Protective Abilities of Interleukin-10 in Blood-Induced Joint Damage.

Nathalie W.D. Jansen, MSc, Joel A.G. Van Roon, Ph.D., Goris Roosendaal, MD/Ph.D., Matthias Theobald, MD/Prof. Ph.D., Johannes W.J. Bijlsma, MD/Prof. Ph.D., Floris P.J.G. Lafeber, Ph.D.

Blood (2007) 110 (11): 494.

https://doi.org/10.1182/blood.V110.11.494.494

Published: 2007

Journal Articles

Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization

Eveline P. Mauser-Bunschoten, Jacco A. C. Zijl, Willem Mali, A. Cees van Rinsum, H. Marijke van den Berg, Goris Roosendaal

Blood (2005) 105 (7): 2654–2657.

https://doi.org/10.1182/blood-2004-06-2063

Published: 2005

Journal Articles

Factor VIII Half-Life and Clinical Characteristics of Severe Hemophilia A.

Karin van Dijk, MD, Johanna G. van der Bom, MD, PhD, Eveline P. Mauser-Bunschoten, MD, PhD, Goris Roosendaal, MD, PhD, Peter J. Lenting, PhD, Philip G. de Groot, PhD, H. Marijke van den Berg, MD, PhD

Blood (2004) 104 (11): 3091.

https://doi.org/10.1182/blood.V104.11.3091.3091

Published: 2004

Journal Articles

Variability in Bleeding Pattern of Severe Hemophilia.

Karin van Dijk, MD, Kathelijn Fischer, MD, PhD, Johanna G. van der Bom, MD, PhD, Eveline P. Mauser-Bunschoten, MD, PhD, Goris Roosendaal, MD, PhD, H. Marijke van den Berg, MD, PhD

Blood (2004) 104 (11): 3094.

https://doi.org/10.1182/blood.V104.11.3094.3094

Published: 2004

Journal Articles

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

Kathelijn Fischer, Johanna G. van der Bom, Eveline P. Mauser-Bunschoten, Goris Roosendaal, Robert Prejs, Piet de Kleijn, Diederick E. Grobbee, Marijke van den Berg

Blood (2002) 99 (7): 2337–2341.

https://doi.org/10.1182/blood.V99.7.2337

Published: 2002

Journal Articles

Hepatitis G Virus RNA and Hepatitis G Virus-E2 Antibodies in Dutch Hemophilia Patients in Relation to Transfusion History

Eveline P. Mauser-Bunschoten, Marjolein Damen, Hans L. Zaaijer, Margret Sjerps, Goris Roosendaal, P. Nico Lelie, H. Theo M. Cuypers, H. Marijke van den Berg

Blood (1998) 92 (6): 2164–2168.

https://doi.org/10.1182/blood.V92.6.2164

Published: 1998

NARROW

IL-1β, in contrast to TNFα, is pivotal in blood-induced cartilage damage and is a potential target for therapy

Interleukin-1β Is Essential for Blood-Induced Cartilage Damage I n Vitro

Insufficient evidence to suggest less stringent therapy in hemophilia B?

Biomarkers of Cartilage and Bone Damage as a Measure of Joint Damage in Haemophilia.

Very Rapid Clearance after a Joint Bleed Knee Can Not Prevent Adverse Effects on Cartilage and Synovial Tissue: A Canine in Vivo Study.

Protective Abilities of Interleukin-10 in Blood-Induced Joint Damage.

Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization

Factor VIII Half-Life and Clinical Characteristics of Severe Hemophilia A.

Variability in Bleeding Pattern of Severe Hemophilia.

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

Hepatitis G Virus RNA and Hepatitis G Virus-E2 Antibodies in Dutch Hemophilia Patients in Relation to Transfusion History

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only